Analysis of adverse events of sunitinib in patients treated for advanced renal cell carcinoma

INTRODUCTION: Treatment of the metastatic stage of renal cell carcinoma is specific because classical chemotherapy is not applicable here. The treatment is mainly based on molecularly targeted drugs, including inhibitors of tyrosine kinases. In many cases the therapy takes many months, and patients...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Arch Med Sci
Egile Nagusiak: Domagała-Haduch, Małgorzata, Cedrych, Ida, Jasiówka, Marek, Niemiec, Maciej, Skotnicki, Piotr
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Termedia Publishing House 2016
Gaiak:
Clinical Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4848366/
https://ncbi.nlm.nih.gov/pubmed/27186181
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/aoms.2016.59262
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak